Sunday, Oct 24, 2021
Focus on the big picture

COVID-19: US FDA, CDC support Pfizer-BioNTech boosters for people high-risk or aged 65+

CA, 24 Sep 2021
The U.S. Food and Drug Administration (FDA) and an advisory panel for the Centers for Disease Control and Prevention have largely approved the use of a third dose of the Pfizer-BioNTech COVID-19 vaccine.

Officials say Americans aged 65 years and older, and those 18 and up who have a high risk for severe disease should receive a booster shot.

Jackson Proskow reports on if Canada is looking to follow suit, and how scientists feel about the general public getting a third dose.

For more info, please go to
Subscribe to Global News Channel HERE:
Like Global News on Facebook HERE:
Follow Global News on Twitter HERE:
Follow Global News on Instagram HERE:
#GlobalNews #COVID19
Related Articles